Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10029


Purpose:

The purpose of this study is to evaluate the drug concentrations of AzaSite compared to Vigamox in tears of healthy volunteers


Criteria:

Inclusion Criteria: - Have visual acuity, using corrective lenses (no contact lenses) if necessary, in both eyes of at least +0.7 as assessed by Early Treatment of Diabetic Retinopathy Study. - Have normal lid anatomy. Exclusion Criteria: - Have an abnormal biomicroscopy or ophthalmoscopy exam. - Have a diagnosis of dry eye disease or have experienced any of the dry eye symptoms (photophobia, foreign body sensation, itching, burning, pain, dry or grittiness) in the past thirty days. - Have used artificial tears in the past thirty days. - Have a diagnosis of on-going ocular infection or lid margin inflammation. - Have ever had penetrating ocular surface or intraocular surgery. - Have a known hypersensitivity to azithromycin, or any macrolide antibiotic or to any of the ingredients in AzaSite. - Have had a known hypersensitivity to Vigamox or any fluoroquinolone antibiotics or to any of the ingredients in Vigamox. - Have had corneal or lid abnormalities. - Have glaucoma, or Intra Ocular Pressure of 22 mm Hg or greater in one or both eyes. - Have any ocular pathology with the exception of cataracts. - Have a serious systemic disease or uncontrolled medical condition. - Have experienced symptoms of viral or allergic conjunctivitis in the past 30 days. - Have a history of liver or kidney disease resulting in persisting dysfunction.


NCT ID:

NCT00575367


Primary Contact:

Study Director
Reza Haque, MD
Merck


Backup Contact:

N/A


Location Contact:

New York, New York 10029
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.